{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:47:53Z","timestamp":1781322473246,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R21AA029771"],"award-info":[{"award-number":["R21AA029771"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["F31AA029295"],"award-info":[{"award-number":["F31AA029295"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["F32AA029288"],"award-info":[{"award-number":["F32AA029288"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K24AA025704"],"award-info":[{"award-number":["K24AA025704"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Alcohol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.alcohol.2024.06.007","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T07:09:19Z","timestamp":1720163359000},"page":"194-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Medication development for AUD: A systematic review of clinical trial methodology"],"prefix":"10.1016","volume":"120","author":[{"given":"S.","family":"Donato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7584-9488","authenticated-orcid":false,"given":"L.R.","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-5211","authenticated-orcid":false,"given":"S.J.","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bujarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5734-9444","authenticated-orcid":false,"given":"L.A.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alcohol.2024.06.007_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/01.ALC.0000091223.72517.13","article-title":"Measuring outcome in interventions for alcohol dependence and problem drinking: Executive summary of a conference sponsored by the national institute on alcohol abuse and alcoholism","author":"Allen","year":"2003","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.alcohol.2024.06.007_bib2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-134-8-200104170-00012","article-title":"The revised CONSORT statement for reporting randomized trials: Explanation and elaboration","volume":"134","author":"Altman","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"17","key":"10.1016\/j.alcohol.2024.06.007_bib53","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined Pharmacotherapies and Behavioral Interventions for Alcohol DependenceThe COMBINE Study: A Randomized Controlled Trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.alcohol.2024.06.007_bib3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/npp.2011.182","article-title":"The alcohol clinical trials initiative (ACTIVE): Purpose and goals for assessing important and salient issues for medications development in alcohol use disorders","volume":"37","author":"Anton","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.alcohol.2024.06.007_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials: The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.alcohol.2024.06.007_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1037\/a0030886","article-title":"The effects of drinking goal on treatment outcome for alcoholism","volume":"81","author":"Bujarski","year":"2013","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.alcohol.2024.06.007_bib6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.15288\/jsad.2014.75.438","article-title":"Predictors of pretreatment commitment to abstinence: Results from the COMBINE study","volume":"75","author":"DeMartini","year":"2014","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.alcohol.2024.06.007_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1016\/j.alcohol.2024.06.007_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamapsychiatry.2018.3079","article-title":"Evaluation of drinking risk levels as outcomes in alcohol pharmacotherapy trials: A secondary analysis of 3 randomized clinical trials","volume":"76","author":"Falk","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.alcohol.2024.06.007_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/acer.13917","article-title":"Gabapentin enacarbil extended-release for alcohol use disorder: A randomized, double-blind, placebo-controlled, multisite trial assessing efficacy and safety","volume":"43","author":"Falk","year":"2019","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"1","key":"10.1016\/j.alcohol.2024.06.007_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/bmjebm-2021-111876","article-title":"Reporting of patient-reported outcomes in trials on alcohol use disorder: A meta-epidemiological study","volume":"28","author":"Douglas","year":"2022","journal-title":"BMJ Evidence-Based Medicine"},{"key":"10.1016\/j.alcohol.2024.06.007_bib11","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1530-0277.2010.01290.x","article-title":"Percentage of subjects with no heavy drinking days: Evaluation as an efficacy endpoint for alcohol clinical trials","volume":"34","author":"Falk","year":"2010","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.alcohol.2024.06.007_bib12","series-title":"Fundamentals of clinical trials","author":"Friedman","year":"2015"},{"key":"10.1016\/j.alcohol.2024.06.007_bib13","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/1471-0528.15199","article-title":"Randomised controlled trials\u2014the gold standard for effectiveness research","volume":"125","author":"Hariton","year":"2018","journal-title":"BJOG: An International Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.alcohol.2024.06.007_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S2215-0366(17)30130-X","article-title":"Change in non-abstinent WHO drinking risk levels and alcohol dependence: A 3 year follow-up study in the US general population","volume":"4","author":"Hasin","year":"2017","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.alcohol.2024.06.007_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3102\/10769986006002107","article-title":"Distribution theory for Glass's estimator of effect size and related estimators","volume":"6","author":"Hedges","year":"1981","journal-title":"Journal of Educational Statistics"},{"key":"10.1016\/j.alcohol.2024.06.007_bib16","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: A systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.alcohol.2024.06.007_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/scientificamerican0811-16","article-title":"A\u00a0dearth of new meds","volume":"305","author":"Kaitin","year":"2011","journal-title":"Scientific American"},{"key":"10.1016\/j.alcohol.2024.06.007_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.drugalcdep.2018.06.015","article-title":"Study characteristics influence the efficacy of substance abuse treatments: A meta-analysis of medications for alcohol use disorder","volume":"190","author":"Klemperer","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.alcohol.2024.06.007_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nrd2828","article-title":"Development of pharmacotherapies for drug addiction: A rosetta stone approach","volume":"8","author":"Koob","year":"2009","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.alcohol.2024.06.007_bib20","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/acer.12197","article-title":"The placebo effect in clinical trials for alcohol dependence: An exploratory analysis of 51 naltrexone and acamprosate studies","volume":"37","author":"Litten","year":"2013","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.alcohol.2024.06.007_bib21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1369-1600.2012.00454.x","article-title":"Medications development to treat alcohol dependence: A vision for the next decade","volume":"17","author":"Litten","year":"2012","journal-title":"Addiction Biology"},{"key":"10.1016\/j.alcohol.2024.06.007_bib22","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/acer.13093","article-title":"Discovery, development, and adoption of medications to treat alcohol use disorder: Goals for the phases of medications development","volume":"40","author":"Litten","year":"2016","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.alcohol.2024.06.007_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/acer.14233","article-title":"Five priority areas for improving medications development for alcohol use disorder and promoting their routine use in clinical practice","volume":"44","author":"Litten","year":"2020","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.alcohol.2024.06.007_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/08897077.2015.1133472","article-title":"Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety","volume":"37","author":"Litten","year":"2016","journal-title":"Substance Abuse"},{"key":"10.1016\/j.alcohol.2024.06.007_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41572-022-00406-1","article-title":"Hazardous drinking and alcohol use disorders","volume":"8","author":"MacKillop","year":"2022","journal-title":"Nature Reviews Disease Primers"},{"issue":"1","key":"10.1016\/j.alcohol.2024.06.007_bib52","article-title":"Alcohol use disorder: The role of medication in recovery","volume":"41","author":"Mason","year":"2021","journal-title":"Alcohol Research: Current Reviews"},{"key":"10.1016\/j.alcohol.2024.06.007_bib26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2017.04.032","article-title":"Emerging pharmacotherapies for alcohol use disorder","volume":"122","author":"Mason","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.alcohol.2024.06.007_bib27","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.2023.19761","article-title":"Pharmacotherapy for alcohol use disorder: A systematic review and meta-analysis","volume":"330","author":"McPheeters","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.alcohol.2024.06.007_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1360-0443.2002.00019.x","article-title":"Mesa grande: A methodological analysis of clinical trials of treatments for alcohol use disorders","volume":"97","author":"Miller","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.alcohol.2024.06.007_bib29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.trci.2017.10.005","article-title":"Drug discovery and development: Role of basic biological research","volume":"3","author":"Mohs","year":"2017","journal-title":"Alzheimer's and Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.alcohol.2024.06.007_bib30","first-page":"36","article-title":"The development of software to support multiple systematic review types: The joanna briggs institute system for the unified management, assessment and review of information (JBI SUMARI)","volume":"17","author":"Munn","year":"2019","journal-title":"JBI Evidence Implementation"},{"key":"10.1016\/j.alcohol.2024.06.007_bib31","first-page":"1","article-title":"Leveraging meta-regression to test if medication effects on cue-induced craving are associated with clinical efficacy","author":"Nieto","year":"2024","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.alcohol.2024.06.007_bib32","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/jama.1995.03530100085040","article-title":"From science to practice: Meta-analyses using individual patient data are needed","volume":"274","author":"Oxman","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.alcohol.2024.06.007_bib33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fphar.2017.00478","article-title":"Hurdles in basic science translation","volume":"8","author":"Perry","year":"2017","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.alcohol.2024.06.007_bib34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s40263-019-00644-0","article-title":"Outcome assessment in trials of pharmacological treatments for alcohol use disorders: Fair and strict testing","volume":"33","author":"R\u00f6sner","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.alcohol.2024.06.007_bib35","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/acer.13829","article-title":"Overcoming the \u201cValley of Death\u201d in medications development for alcohol use disorder","volume":"42","author":"Ray","year":"2018","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.alcohol.2024.06.007_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41386-020-00913-3","article-title":"Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder","volume":"46","author":"Ray","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.alcohol.2024.06.007_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12903","article-title":"The future of translational research on alcohol use disorder","volume":"26","author":"Ray","year":"2021","journal-title":"Addiction Biology"},{"key":"10.1016\/j.alcohol.2024.06.007_bib38","series-title":"9.4 procedures guide","year":"2011"},{"key":"10.1016\/j.alcohol.2024.06.007_bib39","series-title":"strategy","first-page":"1722","article-title":"Baseline severity and the prediction of placebo response in clinical trials for alcohol dependence: A meta-regression analysis to develop an enrichment","volume":"45","author":"Scherrer","year":"2021"},{"key":"10.1016\/j.alcohol.2024.06.007_bib40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0976-500X.72352","article-title":"CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials","volume":"1","author":"Schulz","year":"2010","journal-title":"Journal of Pharmacology and Pharmacotherapeutics"},{"key":"10.1016\/j.alcohol.2024.06.007_bib41","series-title":"EndNote","year":"2013"},{"key":"10.1016\/j.alcohol.2024.06.007_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084779","article-title":"Are reports of randomized controlled trials improving over time? A systematic review of 284 articles published in high-impact general and specialized medical journals","volume":"8","author":"To","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.alcohol.2024.06.007_bib43","article-title":"Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals","volume":"2012","author":"Turner","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.alcohol.2024.06.007_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032024","article-title":"Using the CONSORT statement to evaluate the completeness of reporting of addiction randomised trials: A cross-sectional review","volume":"9","author":"Vassar","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.alcohol.2024.06.007_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"Journal of Statistical Software"},{"key":"10.1016\/j.alcohol.2024.06.007_bib46","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-32483-3_20","article-title":"The clinical benefits of non-abstinent outcomes in alcohol use disorder treatment: Evidence from clinical trials and treatment implications","author":"Votaw","year":"2023","journal-title":"Alcohol and Alcohol-related Diseases"},{"key":"10.1016\/j.alcohol.2024.06.007_bib47","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/13543784.2018.1502269","article-title":"Investigational drug therapies in phase I and phase II clinical trials for alcohol use disorders","volume":"27","author":"Walker","year":"2018","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.alcohol.2024.06.007_bib48","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamapsychiatry.2020.1167","article-title":"Characteristics of ongoing clinical trials for alcohol use disorder registered on ClinicalTrials. gov","volume":"77","author":"Wallach","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.alcohol.2024.06.007_bib49","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/acer.14018","article-title":"Maintenance of World Health Organization risk drinking level reductions and posttreatment functioning following a large alcohol use disorder clinical trial","volume":"43","author":"Witkiewitz","year":"2019","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.alcohol.2024.06.007_bib50","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/acer.12797","article-title":"Guidelines for the reporting of treatment trials for alcohol use disorders","volume":"39","author":"Witkiewitz","year":"2015","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.alcohol.2024.06.007_bib51","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/acer.12800","article-title":"Recommendations for the design and analysis of treatment trials for alcohol use disorders","volume":"39","author":"Witkiewitz","year":"2015","journal-title":"Alcoholism: Clinical and Experimental Research"}],"container-title":["Alcohol"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741832924000934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741832924000934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T12:59:17Z","timestamp":1725973157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741832924000934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":53,"alternative-id":["S0741832924000934"],"URL":"https:\/\/doi.org\/10.1016\/j.alcohol.2024.06.007","relation":{},"ISSN":["0741-8329"],"issn-type":[{"value":"0741-8329","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication development for AUD: A systematic review of clinical trial methodology","name":"articletitle","label":"Article Title"},{"value":"Alcohol","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alcohol.2024.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}